Effectiveness and Safety of Drug-Eluting Stents in Ontario
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The placement of drug-eluting stents decreases the frequency of repeat revascularization procedures in patients undergoing percutaneous coronary intervention (PCI) in randomized clinical trials. However, there is uncertainty about the effectiveness of drug-eluting stents, and increasing concern about their safety, in routine clinical practice. METHODS: From the Cardiac Care Network of Ontario's population-based clinical registry of all patients undergoing PCI in Ontario, Canada, we identified a well-balanced cohort of 3751 pairs of patients, matched on the basis of propensity score, who received either bare-metal stents alone or drug-eluting stents alone during an index PCI procedure between December 1, 2003, and March 31, 2005. The primary outcomes of the study were the rates of target-vessel revascularization, myocardial infarction, and death. RESULTS: The 2-year rate of target-vessel revascularization was significantly lower among patients who received drug-eluting stents than among those who received bare-metal stents (7.4% vs. 10.7%, P<0.001). Drug-eluting stents were associated with significant reductions in the rate of target-vessel revascularization among patients with two or three risk factors for restenosis (i.e., presence of diabetes, small vessels [<3 mm in diameter], and long lesions [> or =20 mm]) but not among lower-risk patients. The 3-year mortality rate was significantly higher in the bare-metal-stent group than in the drug-eluting-stent group (7.8% vs. 5.5%, P<0.001), whereas the 2-year rate of myocardial infarction was similar in the two groups (5.2% and 5.7%, respectively; P=0.95). CONCLUSIONS: Drug-eluting stents are effective in reducing the need for target-vessel revascularization in patients at highest risk for restenosis, without a significantly increased rate of death or myocardial infarction.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Approximately 15% of patients with T2DM will require target vessel revascularization within 2 years after bare metal stenting,290”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [290]
Citations
Cites
Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data
Quan, H., Sundararajan, V., Halfon, P., Fong, A., Burnand, B., Luthi, J.-C., Saunders, L. D., Beck, C. A., Feasby, T. E., & Ghali, W. A. (2005) · Medical Care · doi:10.1097/01.mlr.0000182534.19832.83 · Cited by 10,669
Survival Analysis, Techniques for Censored and Truncated Data
Rao, M. B. (1998) · Technometrics · doi:10.1080/00401706.1998.10485206 · Cited by 3,617
Iakovou, I. (2005) · JAMA · doi:10.1001/jama.293.17.2126 · Cited by 3,132
WRITING COMMITTEE MEMBERS, Smith, S. C., Feldman, T. E., Hirshfeld, J. W., Jacobs, A. K., Kern, M. J., King, S. B., Morrison, D. A., O’Neill, W. W., Schaff, H. V., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.170815 · Cited by 2,218
An Assessment of Clinically Useful Measures of the Consequences of Treatment
Laupacis, A., Sackett, D. L., & Roberts, R. S. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806303182605 · Cited by 1,681
Safety and Efficacy of Sirolimus- and Paclitaxel-Eluting Coronary Stents
Stone, G. W., Moses, J. W., Ellis, S. G., Schofer, J., Dawkins, K. D., Morice, M.-C., Colombo, A., Schampaert, E., Grube, E., Kirtane, A. J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067193 · Cited by 1,631
Late Clinical Events After Clopidogrel Discontinuation May Limit the Benefit of Drug-Eluting Stents
Pfisterer, M., Brunner-La Rocca, H. P., Buser, P. T., Rickenbacher, P., Hunziker, P., Mueller, C., Jeger, R., Bader, F., Osswald, S., & Kaiser, C. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.10.026 · Cited by 1,303
Long-Term Outcomes with Drug-Eluting Stents versus Bare-Metal Stents in Sweden
Lagerqvist, B., James, S. K., Stenestrand, U., Lindbäck, J., Nilsson, T., & Wallentin, L. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067722 · Cited by 1,197
Grines, C. L., Bonow, R. O., Casey, D. E., Gardner, T. J., Lockhart, P. B., Moliterno, D. J., O’Gara, P., & Whitlow, P. (2007) · Circulation · doi:10.1161/circulationaha.106.180944 · Cited by 1,140
Austin, P. C., Grootendorst, P., & Anderson, G. M. (2007) · Statistics in Medicine · doi:10.1002/sim.2580 · Cited by 1,137
Self-citation
Research works printed but not linked: 1
- Wilkins R, 1993, Health Rep, 5, 157
Cited by
Items 301–383 of 383
Drug-Eluting Stent : Present and Future
Park, S. (2008) · Journal of Korean Medical Association · doi:10.5124/jkma.2008.51.4.299 · Cited by 1
Challenges of Measuring the Performance of Health Systems
Levy, A. R., & Sobolev, B. G. (2016) · Springer eBooks · doi:10.1007/978-1-4899-7673-4_19-1 · Cited by 1
Chang, N., Hu, P., Chen, T., Mao, C., Hung, M., Yeh, C., & Hung, M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0227571 · Cited by 1
“Our study demonstrated a significantly lower cumulative incidence of cardiovascular death and primary composite outcome in the DES than BMS group within 1 year but a similar cumulative incidence from 1 year to end of the follow-up, which is similar to that of other studies [54].”
ResultLópez-Aguilar, C., Abundes-Velasco, A., Eid‐Lidt, G., Piña-Reyna, Y., & Gaspar-Hernández, J. (2016) · Archivos de cardiología de México · doi:10.1016/j.acmx.2016.07.003 · Cited by 1
Mølstad, P., Nordrehaug, J. E., Steigen, T. K., Wilsgaard, T., Wiseth, R., & Bønaa, K. H. (2021) · Cardiology · doi:10.1159/000513514 · Cited by 1
Welcher Patient braucht keinen Drug-eluting Stent?
Wenaweser, P. (2009) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 1
Kukreja, N., Onuma, Y., & Serruys, P. W. J. C. (2010) · doi:10.1002/9781444316704.ch34 · Cited by 1
Better results with the new generation bare metal stents
Vik‐Mo, H. (2009) · Scandinavian Cardiovascular Journal · doi:10.1080/14017430802651829 · Cited by 1
“In the Ontario registry, a well-balanced cohort of 3 751 pairs of patients were identified, who matched on the basis of propensity score and who received either BMS or DES alone (16).”
MethodManagement of Multivessel Coronary Disease: Let Us Not Shortchange Drug‐Eluting Stents
Harjai, K. J., & Grines, C. L. (2008) · Journal of Interventional Cardiology · doi:10.1111/j.1540-8183.2008.00362.x · Cited by 1
Sardella, G., Conti, G., Bisceglia, T., Canali, E., Mancone, M., Carlo, C. D., Spedicato, L., Morocutti, G., Fedele, F., & Bernardi, G. (2011) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.23050 · Cited by 1
Costa, J. R., Sousa, A. G. M. R., da Costa, R. A., Moreira, A. C., Cano, M. N., Maldonado, G. A., Carballo, M. T., Neto, C. C., Jardim, C., Pavanello, R., et al. (2009) · Revista Brasileira de Cardiologia Invasiva · doi:10.1590/s2179-83972009000100008 · Cited by 1
PFISTERER, M. E. (2008) · Heart · doi:10.1136/hrt.2008.143883 · Cited by 1
Drug-Eluting Compared With Bare-Metal Coronary Stents Among Elderly Patients
Gersh, B. J. (2009) · Yearbook of Cardiology · doi:10.1016/s0145-4145(09)79499-7 · Cited by 1
Observational studies of drug-eluting stents – some are more equal than others.
Austin, D., Oldroyd, K. G., & Pell, J. P. (2009) · EuroIntervention · doi:10.4244/eijv4i4a73 · Cited by 1
Outcome observations with drug-eluting stents
Steffenino, G. D., & Olivari, Z. (2008) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e3282f4afe5 · Cited by 1
Challenges of Measuring the Performance of Health Systems
Levy, A. R., & Sobolev, B. G. (2019) · Health services research · doi:10.1007/978-1-4939-8715-3_19 · Cited by 1
Hofmann, R. (2008) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Catheter ultrasound for cross-sectional imaging and drug delivery to vessel wall
Hossack, J. A. (2015) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.2182103
“However, DES’s are associated with elevated risk of heart attack or stroke due to thrombosis (blood clotting) [5], [7], [8].”
BackgroundAttizzani, G. F., & Bezerra, H. G. (2010) · Revista Brasileira de Cardiologia Invasiva · doi:10.1590/s2179-83972010000400017
Efetividade e segurança dos stents farmacológicos em um serviço de cardiologia em Curitiba-PR
Braga, C. Y. Y., Rivetti, L. A., & Stella, F. D. P. (2010) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2010005000081
de Quadros, A. S., Gottschall, C. A. M., Diemer, F., Diehl, D. A., Sarmento‐Leite, R., Rodrigues, A. P. D. R., Vizzotto, M. D., Camozzatto, F. O., Martins, J. M. P., Rodrigues, L. H. C., et al. (2008) · Revista Brasileira de Cardiologia Invasiva · doi:10.1590/s2179-83972008000200008
Sirolimus and Paclitaxel Eluting Stent Clinical Studies
Kirtane, A. J., Caixeta, A. M., Généreux, P., Patel, R., & Moses, J. W. (2011) · Interventional Cardiology · doi:10.1002/9781444319446.ch34
Marzocchi, A., Bologna, A. O. S. M., Guastaroba, P., & Romagna, R. E. (2009)
Tan, E. S. (2008) · University of Groningen research database (University of Groningen / Centre for Information Technology)
Cook, S. (2009) · doi:10.1002/9781444314441.ch2
Standortbestimmung der Drug-Eluting-Stents ein Jahr nach Beginn der Sicherheitsdiskussion
Gross, C. M., Schmidt, S., & Bergmann, M. M. (2008) · Clinical Research in Cardiology Supplements · doi:10.1007/s11789-008-0040-1
Seleção de pacientes diabéticos para angioplastia: ampliando o espectro de pacientes
Alves, C. M. R. (2010) · Revista Brasileira de Cardiologia Invasiva · doi:10.1590/s2179-83972010000200004
Park, I., Jeong, M. H., Kim, I. S., Rhee, J. A., Choi, J. S., Park, I. H., Chai, L. S., Jeong, Y. A., Hyun, D. Y., Jeong, H. C., et al. (2015) · Korean Journal of Medicine · doi:10.3904/kjm.2015.89.4.418
Yang, Y.-J., Shin, S., Kim, B., Kim, J., Shin, D., Ko, Y., Choi, D., Jang, Y., & Hong, M. (2012) · Yonsei Medical Journal · doi:10.3349/ymj.2013.54.1.41
“41 pISSN: 0513-5796, eISSN: 1976-2437 Yonsei Med J 54(1):41-47, 2013”
Diferentes procedimentos, diferentes indicações terapêuticas
Filho, J. G. L. (2007) · Brazilian Journal of Cardiovascular Surgery · doi:10.1590/s0102-76382007000400003
“Porém, tenho muitas dúvidas se esse progresso técnico foi acompanhado de benefícios clínicos para os pacientes de uma maneira geral [10,11], excluindo o tratamento na fase aguda do infarto do miocárdio [12,13].”
BackgroundWimmer, N. J., & Yeh, R. W. (2012) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2012.06.006
“Summary, Conclusion, and Future Directions We have reviewed recent research demonstrating individual variability in the efficacy of DES compared to BMS. Importantly, the variable response for an individual can be predicted before PCI.”
BackgroundMethodInfluentialCutlip, D. E. (2008) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.108.834036
The nucleotide analogue 3-deazaadenosine prevents neointima-formation after balloon injury
Seeger, F. H., Hess, W., Sedding, D., Becker, G., Kinscherf, R., Braun-Dullaeus, R. C., Viedt, C., & Kreuzer, J. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.11.151
Tsai, T. T., Maddox, T. M., Rumsfeld, J. S., Ho, P. M., Magid, D. J., Xu, S., Powers, J. D., Carroll, N. M., Shetterly, S. M., Margolis, K. L., et al. (2010) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.110.958587
Choice of DES: A European Clinician's Perspective
Sastry, S., & Morice, M. (2009) · Journal of Interventional Cardiology · doi:10.1111/j.1540-8183.2009.00454.x
Can the restenosis benefit of drug-eluting and bare-metal stents be predicted?
Briguori, C. (2012) · Interventional Cardiology · doi:10.2217/ica.11.97
Highlights from American Heart Association, November 4 to 7, 2007, Orlando, FL
Allen, L. A., Jolicoeur, M. E., Melloni, C., Lópes, R. D., Chan, M. Y., Majidi, M., Piccini, J. P., Berger, J. S., Katz, J. N., & Shah, B. R. (2008) · American Heart Journal · doi:10.1016/j.ahj.2007.12.001
All-Cause Mortality Long-Term Impact of Drug-Eluting Stents Versus Bare-Metal Stents on
Ellis, S. G., Raymond, R. E., Galla, J. M., Brener, S. J., Whitlow, P. L., Shishehbor, M. H., Goel, S. S., Kapadia, S. R., & Bhatt, D. L. (2011)
Chhatriwalla, A. K., Deepak, M., & Bhatt, L. (2016)
Crooks, N., Chan, W., Ivanov, J., Horlick, E. M., Ing, D. J., Overgaard, C. B., & Džavík, V. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.11.024
Stent Thrombosis Following Drug-Eluting Stents in STEMI
Strauss, B. H., & Shuvy, M. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.04.026
“To date, no prospective, randomized studies have shown differences in mortality between DES and BMS, although an “all-comers” Ontario registry study also showed significant differences in survival for first-generation DES patients in a propensity analysis (11).”
BackgroundResultados Tardios de Pacientes Submetidos a Implante de Stents Farmacológicos do Registro SAFIRA
Barbosa, D. D. O. N., Marchini, J. F. M., Ghandour, M. S., Bezerra, B. V., Cristóvão, S. A. B., Carnieto, N. M., Erudilho, E., Salman, A. A., Mauro, M. F. Z., & Mangione, J. A. (2014) · Revista Brasileira de Cardiologia Invasiva · doi:10.1590/0104-1843000000006
Selection of Patients for Drug-Eluting Stents Based on Insurance Coverage
Krone, R. J. (2010) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2010.05.006
Diabetes and Drug-Eluting Stents
Marso, S. P. (2008) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2008.02.004
Perkütan Koroner Giriflim Sonras› Kalp Dfl› Cerrahi
Emiro¤lu, Y., Pala, S., & Boztosun, B. (2015) · DergiPark (Istanbul University)
Coverage with Evidence Development in Comparative Effectiveness Research
Diaby, V., & Goeree, R. A. (2015) · Springer eBooks · doi:10.1007/978-1-4899-7586-7_17-1
Self-citationEffectiveness and Safety of Drug-Eluting Stents in Ontario
Gersh, B. J. (2008) · Yearbook of Cardiology · doi:10.1016/s0145-4145(08)04053-7
Why we should never return to bare metal stents?
Morice, M. (2008) · EuroIntervention · doi:10.4244/eijv4i1a7
Drug-Eluting Stents vs. Bare-Metal Stents: The Ontario Experience
Herrmann, H. C. (2007) · Journal watch · doi:10.1056/jc200710030000001
Current market trends of cardiac stents
Cayton, J., Kennedy, T., O'Dell, B., Stine, M., & Lee, D. (2012) · Journal of Medical Marketing Device Diagnostic and Pharmaceutical Marketing · doi:10.1177/1745790411435437
Meier, B., Windecker, S., Ērglis, A., Chechi, T., Ortolani, P., Schalij, M. J., Vermeersch, P. H. M. J., Červinka, P., SUTTORP, M. J., Kelbæk, H., et al. (2008)
Antiplatelet Therapy in the Patient with Coronary Stent Undergoing Surgery and Dental Procedure
Chamnarnphol, N. (2011) · DOAJ (DOAJ: Directory of Open Access Journals)
Percutaneous coronary intervention for unprotected left main coronary artery stenosis
Park, S., & Kim, Y. (2009) · Interventional Cardiology · doi:10.2217/ica.09.1
Drug-Eluting Stents: Segen oder Zeitbombe?
Lüscher, T. F., & Steffel, J. (2008) · Swiss Medical Forum ‒ Schweizerisches Medizin-Forum · doi:10.4414/smf.2008.06378
Calculation of Number Needed to Treat
Baughman, K. L. (2009)
Off-label use of coronary drug-eluting stents
Roszek, B., de, W. R., Jwga, P., & Re, G. (2009) · Rivm Repository (Netherlands National Institute for Public Health and the Environment)
Historical Perspective of Sirolimus and Paclitaxel‐Eluting Stent Clinical Studies
Caixeta, A. M., Guimaraes, L. D. F. C., Généreux, P., & Dangas, G. (2016) · Interventional Cardiology · doi:10.1002/9781118983652.ch31
Rashid, S. (2016) · Journal of Cardiology & Cardiovascular Therapy · doi:10.19080/jocct.2016.01.555570
“However, very late stent thrombosis (>1 year) increases with DES [2-5].”
BackgroundDeb, S., Austin, P. C., Tu, J. V., Ko, D. T., Mazer, C. D., Kiss, A., & Fremes, S. E. (2016)
Self-citationWijeysundera, H. C. (2012) · TSpace (University of Toronto)
Yun, C., Braga, Y., Rivetti, L. A., & Stella, F. D. P. (2010)
Late Outcomes of Patients Undergoing Drug-Eluting Stent Implantation – The SAFIRA Registry
Barbosa, D. D. O. N., Marchini, J. F. M., Ghandour, M. S., Bezerra, B. V., Cristóvão, S. A. B., Carnieto, N. M., Erudilho, E., Salman, A. A., Mauro, M. F. Z., & Mangione, J. A. (2014) · Revista Brasileira de Cardiologia Invasiva (English Edition) · doi:10.1016/s2214-1235(15)30175-7
The Influence of Preoperative Antithrombotic Therapy in Patients with Thoracic Surgery
Furuichi, M., Sugito, K., Shimamura, M., Nishii, T., Takeshita, S., Ishimoto, S., Tanaka, Y., Morooka, H., Higure, R., & Shiono, M. (2014) · Journal of Nihon University Medical Association · doi:10.4264/numa.73.248
Myocardial infarction: temporal trends over the past three decades
Nauta, S. T. (2015) · EUR Research Repository (Erasmus University Rotterdam)
Krone, R. J., Rao, S. V., Dai, D., Anderson, H. V., Peterson, E. D., Brown, M., Brindis, R. G., Klein, L. W., Shaw, R. E., & Weintraub, W. S. (2010)
Ko, D. T., Wijeysundera, H. C., Udell, J. A., Vaccarino, V., Austin, P. C., Guo, H., Velianou, J. L., Lau, K., & Tu, J. V. (2014)
Self-citationObservational methods in cardiovascular outcomes research
Federspiel, J. J. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/j5d7-4g28
Actualización en cardiología intervencionista
Pinar, E., Albarrán, A., Baz, J. A., & Mauri, J. (2009) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(09)71776-5
Choice of Stents and Clinical Outcomes in Patients with Chronic Kidney Disease
Li, S. X., & Baber, U. (2020) · Springer eBooks · doi:10.1007/978-3-030-45414-2_7
Investigation and Management of Coronary Artery Disease Among Patients with Heart Failure in Ontario
Braga, J. R. (2020) · TSpace (University of Toronto)
Vascular Restenosis and Midkine
Kadomatsu, K. (2012) · Springer eBooks · doi:10.1007/978-94-007-4234-5_10
Regulations for Substitutable Medical DevicesPreprint
Zhou, F., Nassiri, S., & Anupindi, R. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3937488
Late Outcomes of Patients Undergoing Drug-Eluting Stent Implantation – The SAFIRA Registry
Barbosa, D. D. O. N., Marchini, J. F. M., Ghandour, M. S., Bezerra, B. V., Cristóvão, S. A. B., Carnieto, N. M., Erudilho, E., Salman, A. A., Mauro, M. F. Z., & Mangione, J. A. (2014) · Revista Brasileira de Cardiologia Invasiva · doi:10.1016/s0104-1843(14)50006-9
Percutaneous Coronary Intervention for Unprotected Left Main Coronary Artery Stenosis
Park, S., & Kim, Y. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-2358-8.00022-x
Coverage with Evidence Development in Comparative Effectiveness Research
Diaby, V., & Goeree, R. A. (2016) · Springer eBooks · doi:10.1007/978-1-4899-7600-0_17
Self-citationCook, S., & Windecker, S. (2010) · CRC Press eBooks · doi:10.3109/9780203093047-33
Managing Stable Coronary Artery Disease in Diabetes
Koulouridis, I., & Johnstone, M. T. (2023) · Contemporary cardiology · doi:10.1007/978-3-031-13177-6_23
Percutane behandeling van coronaire atherotrombose
Jessurun, G. A. J., & Zijlstra, F. (2008) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-6597-5_7
Ectopic Pregnancy risk factors among the patients referred to Shariati hospital in Bandarabbas
Rajaee, M., Zamani, M., Salagegheh, N., Mahboobi, H., & Khorgoei, T. (2011) · DOAJ (DOAJ: Directory of Open Access Journals)
Coronary Angioplasty and Drug-Eluting Stents
Jain, K. K. (2011) · Humana Press eBooks · doi:10.1007/978-1-61779-240-3_9
Metadata
- Authors
- Tu, J. V., Bowen, J., Chiu, M., Ko, D. T., Austin, P. C., He, Y., Hopkins, R., Tarride, J.-E., Blackhouse, G., Lazzam, C., Cohen, E. A., & Goeree, R.
- Affiliations
- Sunnybrook Health Science Centre (CA)
- St. Joseph’s Healthcare Hamilton (CA)
- Institute for Clinical Evaluative Sciences (CA)
- Trillium Health Centre (CA)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-10-04
- Volume
- 357
- Issue
- 14
- Pages
- 1393-1402
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2082511254
- Cited by
- 383
- References
- 35
- Citations by year
- 2024: 1 · 2023: 1 · 2022: 2 · 2021: 5 · 2020: 11 · 2019: 7 · 2018: 5 · 2017: 13 · 2016: 15 · 2015: 28 · 2014: 15 · 2013: 15 · 2012: 34
- FWCI
- 67.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Keywords
- drug-eluting stents, bare-metal stents, percutaneous coronary intervention, target vessel revascularization, restenosis, myocardial infarction, mortality, diabetes mellitus, long coronary lesions, propensity score matching, clinical registries, Ontario
- MeSH terms
- Female, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Infarction, Ontario, Prosthesis Design, Registries, Risk Factors, Stents, Angioplasty, Balloon, Coronary, Drug Delivery Systems, Myocardial Ischemia, Disease-Free Survival, Coronary Restenosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.